官方服务：
资源简介：
Propranolol inhibition of melanoma growth
应用场景：
创建时间：
2014-05-30
相关数据集
Table S1 from Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
Cell line sources, information, and growth conditions
NIAID Data Ecosystem70
DataSheet5_Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression.CSV
Cancer can develop due to abnormal cell proliferation in any body’s cells, so there are over a hundred different types of cancer, each with its distinct behavior and response to treatment. Therefore,
NIAID Data Ecosystem60
Univariate e multivariate analysis of factors associated to progression-free survival (PFS) in BRAF mutated melanoma patients treated with dabrafenib and trametinib.
Univariate e multivariate analysis of factors associated to progression-free survival (PFS) in BRAF mutated melanoma patients treated with dabrafenib and trametinib.
Figshare2019-04-02 更新10
Supplementary Material for: Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF -V600 + MEK Inhibitors for Advanced Melanoma
Background: Combined treatment with BRAF -V600 and MEK inhibitors has significantly improved progression-free and overall survival of patients with BRAF -mutated melanoma. Pa
DataCite Commons2020-08-28 更新70
MRT cell lines are sensitive to pharmacological FGFR inhibition.
(A) Global compound selectivity analysis of MRT lines. Comparison of the three MRT lines A204, G401 and G402 versus other soft tissue cancer lines from the CCLE with regards to sensitivity to a panel
NIAID Data Ecosystem40
